Print Page

給 醫 護 專 業 人 員 的 信
 
Xtandi™ (enzalutamide) Interference with Laboratory Test CMIA leading to Falsely Elevated Digoxin Plasma Levels (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Xtandi™ (enzalutamide) Interference with Laboratory Test CMIA leading to Falsely Elevated Digoxin Plasma Levels (Letter to Healthcare Professionals) (English only)  
Related Information:
Canada: Safety brief: Falsely elevated digoxin levels with the chemiluminescent ... 上載於 2026-05-02
Singapore: Xtandi™ (enzalutamide) interference with laboratory test CMIA leading... 上載於 2026-01-16
 
back